Asked by: Margaret Hodge (Labour - Barking)
Question to the Department for Levelling Up, Housing & Communities:
To ask the Secretary of State for Levelling Up, Housing and Communities, if he will take steps to help leaseholders with premium insurance rates for multi-occupancy residential buildings affected by (a) flammable cladding and (b) other material safety risks.
Answered by Lee Rowley - Minister of State (Minister for Housing)
The Government continues to put extreme pressure into ensuring more fair and proportionate premiums for leaseholders living in multi-occupancy buildings with fire safety issues.
The FCA recommended that the insurance industry develop a risk-sharing facility for buildings with fire-safety issues. The Association of British Insurers’ Fire Safety Reinsurance Facility launched on 1 April 2024 in response to this recommendation. We are closely monitoring the Facility to understand the extent to which it improves outcomes for leaseholders.
On 31 December 2023, FCA changes came into force to give leaseholders rights under Fair Value rules and require the disclosure of key policy information. We welcome these changes and expect that they will help reduce the unfair costs facing leaseholders.
On 27 November 2023, the Leasehold and Freehold Reform Bill was introduced into Parliament. The Bill bans insurance commissions being passed to freeholders and managing agents, replacing these with transparent handling fees. This will stop leaseholders being charged excessive and opaque commissions on top of their premiums.
The Government has also published a commitment by 14 insurance broker companies to cap their commissions to 15%, stop sharing commissions with managing agents, landlords and freeholders, and share policy information with leaseholders when requested. The pledge will benefit leaseholders in buildings over 11 metres (or four storeys) in height with identified fire safety defects, where these details have been made known to the insurance broker.
We will continue to monitor the impact these changes have had on leaseholder premiums, and will remain engaged with industry regarding whether any further steps may be required.
Asked by: Rosie Duffield (Labour - Canterbury)
Question to the Department for Levelling Up, Housing & Communities:
To ask the Secretary of State for Levelling Up, Housing and Communities, if he will make an assessment of the potential merits of updating the National Planning Policy Framework to enable local planning authorities to use the most recent Office for National Statistics household projections in the standard method of calculating local housing need.
Answered by Lee Rowley - Minister of State (Minister for Housing)
A review of the standard method formula was undertaken in 2020. As part of the consultation, we asked if we should incorporate more recent household projections data into the formula. Following careful consideration of the responses received, to provide stability and certainty for local authorities and other stakeholders we decided to retain the existing formula.
We have kept the standard method under review. Through a consultation on changes to national policy held in 2022/23 we committed to review our approach to assessing housing needs once new household projections data, based on the 2021 Census, is released in 2025.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what steps she is taking with allies to secure semiconductor supply chains in the context of heightened tensions in the Taiwan Strait.
Answered by Saqib Bhatti - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
Safeguarding the UK against supply chain disruptions is a key pillar of the UK National Semiconductor Strategy, and international collaboration is crucial to achieving this. The UK Government works closely with international partners, including through semiconductor partnerships with Japan and the Republic of Korea. These partnerships explore shared approaches and solutions to improve global supply chain resilience and aim to establish areas of collaboration for mutual strategic advantage. Multilaterally, the UK Government is engaging with the G7 and the OECD Semiconductor Informal Exchange Network to strengthen understanding and coordination of global supply chain risks.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, whether she has had discussions with her international counterparts on coordinating the global response to potential disruptions of semiconductor manufacturing as a result of geopolitical tensions.
Answered by Saqib Bhatti - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
The UK Government is working closely with international partners and has already signed semiconductor partnerships with Japan, the Republic of Korea and the US. These partnerships encourage greater transparency in the semiconductor market, place an increased focus on improving supply chain resilience, and establish areas of collaboration for mutual strategic advantage. Multilaterally, the UK Government is engaging with the G7 and the OECD Semiconductor Informal Exchange Network to strengthen understanding and coordination of global supply chain risks.
Asked by: Matt Rodda (Labour - Reading East)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, whether her Department expects to send ministerial representatives to the South Korean AI safety summit.
Answered by Saqib Bhatti - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
As this is a co-hosted Summit between the Republic of Korea and the United Kingdom, the Government can confirm that the Secretary of State will be attending the Summit in Seoul. At this moment, the Government cannot confirm if there will be any other ministerial representatives to attend in the Summit.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to section 1.17 of the National Institute for Health and Care Excellence (NICE) guidelines entitled Myalgic encephalomyelitis (or encephalopathy) chronic fatigue syndrome: diagnosis and management, published on 29 October 2021, what steps her Department is taking to help ensure that hospital staff are aware of NICE guidelines for caring patients with very severe myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 March 2024 to Question 16630 on Chronic Fatigue Syndrome, when she plans to publish the final myalgic encephalomyelitis delivery plan.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Matt Rodda (Labour - Reading East)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's consultation outcome entitled A pro-innovation approach to AI regulation: Government response, CP 1019, updated on 6 February 2024, what progress her Department has made on boosting AI research through the launch of nine new research hubs across the UK.
Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)
UK research and Innovation’s Engineering and Physical Sciences Research Council (EPSRC) has invested £86 million in new research hubs that will propel the UK to the forefront of advanced AI research. The hubs are broad consortia of universities and businesses, which will leverage the UK’s world leading AI research, connecting universities and businesses and creating spinouts who will deliver next-generation innovations and technologies.
This focussed investment will enable AI to evolve and tackle complex problems across applications from healthcare treatments to power-efficient electronics, transforming the way we develop and use AI, and is part of a larger investment of over £300 million in AI research and training by EPSRC over the past 12 months, safeguarding the UK’s digital future.
Asked by: Matt Rodda (Labour - Reading East)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's consultation outcome entitled A pro-innovation approach to AI regulation: Government response, CP 1019, updated on 6 February 2024, how much of the £10m to jumpstart regulator’s AI capabilities has been allocated.
Answered by Saqib Bhatti - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
The Government is moving at pace to design the mechanism for allocating the £10m funding to jumpstart regulator capabilities. The Government is actively engaging with regulators to ensure this is delivered in a way that best supports their needs. The Government expects to launch the fund this summer and will allocate the funding during the course of this financial year and 25/26.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to increase inpatient provision for patients with myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.